Clinical Trials
Study Title:
Randomized, Phase III Study of Early Intervention With Venetoclax and Obinutuzumab Versus Delayed Therapy With Venetoclax and Obinutuzumab in Newly Diagnosed Asymptomatic High Risk Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): EVOLVE CLL/SLL Study
For more information about the trial above please contact the study team:
Medical University of South Carolina Principal Investigator, Brian Hess, at hessbr@musc.edu. Study Coordinator, Hana Baker, at bakerhan@musc.edu.
Trial opened at the following institutions: Medical University of South Carolina, Ralph H. Johnson VAMC |